GRTX - Galera Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
-1.46 (-11.02%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close13.25
Bid0.00 x 2200
Ask0.00 x 900
Day's Range11.75 - 13.25
52 Week Range11.50 - 14.49
Avg. Volume344,642
Market Cap287.229M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Galera Therapeutics Announces Pricing of Initial Public Offering

    Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced the pricing of its initial public offering of 5,000,000 shares of common stock at a public offering price of $12.00 per share, for total gross proceeds of $60.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Galera. All of the common stock is being offered by Galera.

  • We're sorry this is all we were able to find about this topic.